Exact Mass: 258.1732

Exact Mass Matches: 258.1732

Found 45 metabolites which its exact mass value is equals to given mass value 258.1732, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(-)-Pseudophrynaminol

(-)-Pseudophrynaminol

C16H22N2O (258.1732)


   
   

11-hydroxy lycodine

11-hydroxy lycodine

C16H22N2O (258.1732)


   

(+/-)-lycoposerramine R|(4aS,6R,7aS,12bS)-1,2,3,4,4a,5,6,7,7a,8-decahydro-6-methylpyrido[2,3:4,5]-cyclopenta[1,2-c]-quinolin-10(9H)-one|lycoposerramine-R

(+/-)-lycoposerramine R|(4aS,6R,7aS,12bS)-1,2,3,4,4a,5,6,7,7a,8-decahydro-6-methylpyrido[2,3:4,5]-cyclopenta[1,2-c]-quinolin-10(9H)-one|lycoposerramine-R

C16H22N2O (258.1732)


   

(-)-lyconadin B|lyconadin B|lyconadine B

(-)-lyconadin B|lyconadin B|lyconadine B

C16H22N2O (258.1732)


   

nigerazine B

nigerazine B

C16H22N2O (258.1732)


An enamide obtained by formal condensation of the carboxy group of trans-cinnamic acid with the secondary amino group of (2S,5R)-1,2,5-trimethylpiperazine.

   

5,17-didehydro-matridin-15-one|Darvasin

5,17-didehydro-matridin-15-one|Darvasin

C16H22N2O (258.1732)


   

De-N-methyl-beta-obscurine|des-N-methyl-beta-obscurine|huperzine B|N-demethyl-beta-obscurine

De-N-methyl-beta-obscurine|des-N-methyl-beta-obscurine|huperzine B|N-demethyl-beta-obscurine

C16H22N2O (258.1732)


   

Methylmadugin

Methylmadugin

C16H22N2O (258.1732)


   

casuarinine G

casuarinine G

C16H22N2O (258.1732)


   

casuarinine J

casuarinine J

C16H22N2O (258.1732)


   

(-)-lyconadin C|lyconadin C

(-)-lyconadin C|lyconadin C

C16H22N2O (258.1732)


   

(E)-2-methyl-4-((3aS)-1-methyl-2,3,8,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-en-1-ol

(E)-2-methyl-4-((3aS)-1-methyl-2,3,8,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-en-1-ol

C16H22N2O (258.1732)


   

3-ETHYL-3-METHYL-1-(PIPERIDIN-4-YL)INDOLIN-2-ONE

3-ETHYL-3-METHYL-1-(PIPERIDIN-4-YL)INDOLIN-2-ONE

C16H22N2O (258.1732)


   

2-methylamino-5-mercapto-1,3,4-thiadiazole

2-methylamino-5-mercapto-1,3,4-thiadiazole

C16H22N2O (258.1732)


   

4-(2,3-dihydrospiro[indene-1,2-pyrrolidine]-6-yl)Morpholine

4-(2,3-dihydrospiro[indene-1,2-pyrrolidine]-6-yl)Morpholine

C16H22N2O (258.1732)


   

1H-1-Benzazepine-1-carboxamide,N-cyclopentyl-2,3,4,5-tetrahydro-(9CI)

1H-1-Benzazepine-1-carboxamide,N-cyclopentyl-2,3,4,5-tetrahydro-(9CI)

C16H22N2O (258.1732)


   

1-(1-Benzylpiperidin-4-yl)pyrrolidin-2-one

1-(1-Benzylpiperidin-4-yl)pyrrolidin-2-one

C16H22N2O (258.1732)


   

9-Benzyl-3,9-Diazaspiro[5.5]Undecan-2-One

9-Benzyl-3,9-Diazaspiro[5.5]Undecan-2-One

C16H22N2O (258.1732)


   

(2E)-3-phenyl-1-[(2R,5S)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

(2E)-3-phenyl-1-[(2R,5S)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

C16H22N2O (258.1732)


   

4-(1-methyl-3-indolyl)-N-propan-2-ylbutanamide

4-(1-methyl-3-indolyl)-N-propan-2-ylbutanamide

C16H22N2O (258.1732)


   

(2E)-3-phenyl-1-[(2R,5R)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

(2E)-3-phenyl-1-[(2R,5R)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

C16H22N2O (258.1732)


   

nigerazine A

nigerazine A

C16H22N2O (258.1732)


An enamide obtained by formal condensation of the carboxy group of trans-cinnamic acid with the secondary amino group of (2R,5R)-1,2,5-trimethylpiperazine.

   

NA-Tryptamine 6:0

NA-Tryptamine 6:0

C16H22N2O (258.1732)


   

11-methyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6-trien-5-ol

11-methyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6-trien-5-ol

C16H22N2O (258.1732)


   

(3e)-2-methyl-4-{3-[2-(methylamino)ethyl]-1h-indol-4-yl}but-3-en-2-ol

(3e)-2-methyl-4-{3-[2-(methylamino)ethyl]-1h-indol-4-yl}but-3-en-2-ol

C16H22N2O (258.1732)


   

(1r,9s,10r,11r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-11-ol

(1r,9s,10r,11r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-11-ol

C16H22N2O (258.1732)


   

(1s,4s,8s)-3-[(8as)-1,2,3,5,6,8a-hexahydroindolizin-8-yl]-8-methyl-2-azabicyclo[2.2.2]oct-2-en-5-one

(1s,4s,8s)-3-[(8as)-1,2,3,5,6,8a-hexahydroindolizin-8-yl]-8-methyl-2-azabicyclo[2.2.2]oct-2-en-5-one

C16H22N2O (258.1732)


   

(2e)-3-phenyl-1-[(2s,5r)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

(2e)-3-phenyl-1-[(2s,5r)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

C16H22N2O (258.1732)


   

16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-11-ol

16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-11-ol

C16H22N2O (258.1732)


   

3-phenyl-1-(2,4,5-trimethylpiperazin-1-yl)prop-2-en-1-one

3-phenyl-1-(2,4,5-trimethylpiperazin-1-yl)prop-2-en-1-one

C16H22N2O (258.1732)


   

2-methyl-4-{1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl}but-2-en-1-ol

2-methyl-4-{1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl}but-2-en-1-ol

C16H22N2O (258.1732)


   

(1s,9s,11r,13s,17r)-11-methyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6-trien-5-ol

(1s,9s,11r,13s,17r)-11-methyl-6,14-diazatetracyclo[7.6.2.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6-trien-5-ol

C16H22N2O (258.1732)


   

(1r,9s,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-5-ol

(1r,9s,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-5-ol

C16H22N2O (258.1732)


   

n-[2-(1h-indol-3-yl)ethyl]-n,3-dimethylbutanamide

n-[2-(1h-indol-3-yl)ethyl]-n,3-dimethylbutanamide

C16H22N2O (258.1732)


   

3-(1,2,3,5,6,8a-hexahydroindolizin-8-yl)-8-methyl-2-azabicyclo[2.2.2]oct-2-en-5-one

3-(1,2,3,5,6,8a-hexahydroindolizin-8-yl)-8-methyl-2-azabicyclo[2.2.2]oct-2-en-5-one

C16H22N2O (258.1732)


   

(2e)-4-[(3as,8as)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]-2-methylbut-2-en-1-ol

(2e)-4-[(3as,8as)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]-2-methylbut-2-en-1-ol

C16H22N2O (258.1732)


   

14-methyl-1,4-diazapentacyclo[7.7.1.0²,¹².0³,⁸.0¹¹,¹⁶]heptadeca-3(8),4-dien-5-ol

14-methyl-1,4-diazapentacyclo[7.7.1.0²,¹².0³,⁸.0¹¹,¹⁶]heptadeca-3(8),4-dien-5-ol

C16H22N2O (258.1732)


   

(1r,9s,10r,16s)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-5-ol

(1r,9s,10r,16s)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-5-ol

C16H22N2O (258.1732)


   

(2e)-4-[(3ar,8ar)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]-2-methylbut-2-en-1-ol

(2e)-4-[(3ar,8ar)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]-2-methylbut-2-en-1-ol

C16H22N2O (258.1732)


   

2-methyl-4-{3-[2-(methylamino)ethyl]-1h-indol-4-yl}but-3-en-2-ol

2-methyl-4-{3-[2-(methylamino)ethyl]-1h-indol-4-yl}but-3-en-2-ol

C16H22N2O (258.1732)


   

16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-5-ol

16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-5-ol

C16H22N2O (258.1732)


   

(2e)-3-phenyl-1-[(2s,5s)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

(2e)-3-phenyl-1-[(2s,5s)-2,4,5-trimethylpiperazin-1-yl]prop-2-en-1-one

C16H22N2O (258.1732)


   

(2r,9s,11r,12r,14r,16s)-14-methyl-1,4-diazapentacyclo[7.7.1.0²,¹².0³,⁸.0¹¹,¹⁶]heptadeca-3(8),4-dien-5-ol

(2r,9s,11r,12r,14r,16s)-14-methyl-1,4-diazapentacyclo[7.7.1.0²,¹².0³,⁸.0¹¹,¹⁶]heptadeca-3(8),4-dien-5-ol

C16H22N2O (258.1732)


   

(1s,9r,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-11-ol

(1s,9r,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-trien-11-ol

C16H22N2O (258.1732)